Litigation

Recent Posts

Lawsuits Follow Diabetes Drug Actos' Link To Cancer Risk
Posted on 9 Aug 2011 by LexisNexis Litigation Resource Community Staff

TRENTON, N.J. - (AP) The maker of the world's best-selling diabetes drug is facing hundreds of lawsuits and likely a big sales drop as suspicion grows that taking the pill for more than a year raises the risk of bladder cancer. In June, Takeda Pharmaceuticals... Read More

Glaxo Adds Safety Restrictions To Avandia Label
Posted on 9 Feb 2011 by LexisNexis Litigation Resource Community Staff

WASHINGTON, D.C. - (AP) GlaxoSmithKline PLC said Monday it has updated the labeling of its diabetes pill Avandia to include safety restrictions ordered by federal health authorities because of the drug's links to heart attack. The Food and Drug Administration... Read More

Most FDA Advisers Recommend Avandia Stay On The Market
Posted on 14 Jul 2010 by Tom Moylan

GAITHERSBURG, Md. - (Mealey's) A majority of Food and Drug Administration advisers voted July 14 to keep Avandia on the market but split on whether the anti-diabetes drug made by GlaxoSmithKline PLC (GSK) should carry additional warnings about its... Read More

2 Attorneys Settle Their Avandia Cases In Federal, State Courts
Posted on 10 May 2010 by Tom Moylan

PHILADELPHIA — (Mealey’s) Two attorneys have settled their Avandia personal injury cases in federal and state courts with defendant GlaxoSmithKline plc, a source told Mealey Publications May 10. According to the source, W. Mark Lanier of... Read More